Literature DB >> 19155002

Polycystic ovary syndrome and abnormalities in glucose tolerance.

Sudhindra M Bhattacharya1.   

Abstract

OBJECTIVES: To compare the prevalence of abnormal glucose tolerance (AGT) among women with polycystic ovary syndrome (PCOS) and controls, and assess risk factors associated with PCOS.
METHOD: A fasting oral glucose tolerance test after ingestion of 75 g of glucose was administered to 264 women with and 116 without PCOS. Moreover, fasting glucose, insulin, and testosterone levels were measured in the women with PCOS. Body mass index (BMI), waist-to-hip ratio (WHR), and homeostasis model assessment-insulin resistance (HOMA-IR) were calculated for each woman with PCOS.
RESULTS: The AGT prevalence was 14.4% in the PCOS group and 11.2% in the control group (P=0.17). The women with both PCOS and AGT had significantly higher BMIs, WHRs, testosterone levels, and HOMA-IR values than those with normal glucose tolerance.
CONCLUSION: While AGT was not associated with PCOS, the women with both PCOS and AGT were significantly more obese, hyperandrogenic, and insulin resistant than those with PCOS and normal glucose tolerance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19155002     DOI: 10.1016/j.ijgo.2008.11.031

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  3 in total

1.  Insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes.

Authors:  Moamar Al-Jefout; Nedal Alnawaiseh; Aiman Al-Qtaitat
Journal:  Sci Rep       Date:  2017-07-13       Impact factor: 4.379

Review 2.  Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review.

Authors:  Sarantis Livadas; Panagiotis Anagnostis; Julia K Bosdou; Dimitra Bantouna; Rodis Paparodis
Journal:  World J Diabetes       Date:  2022-01-15

3.  Can dysglycemia in OGTT be predicted by baseline parameters in patients with PCOS?

Authors:  Sarantis Livadas; Christina Bothou; Justyna Kuliczkowska-Płaksej; Ralitsa Robeva; Andromahi Vryonidou; Jelica Bjekic Macut; Ioannis Androulakis; Milica Opalic; Zadalla Mouslech; Andrej Milewicz; Alessandra Gambineri; Dimitrios Panidis; Djuro Macut
Journal:  Endocr Connect       Date:  2022-04-22       Impact factor: 3.221

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.